Janux Therapeutics, Inc. (JANX)
18.00
-0.78
(-4.15%)
USD |
NASDAQ |
Aug 28, 16:00
18.21
+0.21
(+1.17%)
After-Hours: 19:46
Janux Therapeutics Total Liabilities (Quarterly) : 79.67M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 79.67M |
| March 31, 2026 | 86.69M |
| December 31, 2025 | 50.70M |
| September 30, 2025 | 48.21M |
| June 30, 2025 | 41.70M |
| March 31, 2025 | 38.30M |
| December 31, 2024 | 38.74M |
| September 30, 2024 | 38.92M |
| June 30, 2024 | 33.74M |
| March 31, 2024 | 33.22M |
| December 31, 2023 | 36.06M |
| September 30, 2023 | 37.90M |
| Date | Value |
|---|---|
| June 30, 2023 | 42.03M |
| March 31, 2023 | 41.69M |
| December 31, 2022 | 43.27M |
| September 30, 2022 | 44.24M |
| June 30, 2022 | 41.55M |
| March 31, 2022 | 12.52M |
| December 31, 2021 | 13.50M |
| September 30, 2021 | 14.33M |
| June 30, 2021 | 12.03M |
| March 31, 2021 | 11.24M |
| December 31, 2020 | 9.231M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| MacroGenics, Inc. | 302.54M |
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 83.95B |
| Anika Therapeutics, Inc. | 46.19M |
| BioCryst Pharmaceuticals, Inc. | 1.012B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.008B |
| Shareholders Equity (Quarterly) | 927.98M |
| Debt to Equity Ratio | 0.0226 |
| Current Ratio | 16.35 |
| Net Debt Paydown Yield | 0.03% |